Clinical Trials Browser

Phase 1 × Ferrosoferric Oxide × Gastrointestinal × Clear all

NCT01770353 2019-11-27

MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment

Phase 1 Completed

45 enrolled 33 charts

BreastGastrointestinalGynecologicHead & Neck

Head and Neck Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT02689401 2016-05-13

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

Phase 1 Withdrawn

Gastrointestinal

Esophageal Neoplasms